跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Spikevax Bivalent Original/Omicron BA.4-5 (50 micrograms/50 micrograms)/mL dispersion for injection - HSA Drug Approval Details
Approvals
/
HSA
/
Spikevax Bivalent Original/Omicron BA.4-5 (50 micrograms/50 micrograms)/mL dispersion for injection
Approved
STANDARD
Spikevax Bivalent Original/Omicron BA.4-5 (50 micrograms/50 micrograms)/mL dispersion for injection
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
b7e886b33e9eefe3
Company
Unknown
Type
Standard
Approval Details
Approval Id
b7e886b33e9eefe3
Drug Name
Spikevax Bivalent Original/Omicron BA.4-5 (50 micrograms/50 micrograms)/mL dispersion for injection
Active Ingredients
Davesomeran
50mcg/mL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
b7e886b33e9eefe3
Type
Standard
Back to HSA Approvals
